Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Teijin Expands Health Care Operations for Bone and Joint Diseases

Filed Under: Pharma Tagged With: , , , , , , , ,

Teijin Ltd. (TYO:3401) is taking measures to expand its product lineup for bone and joint diseases, a strategic area in…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Teijin to Produce Prosthetic Joints in Thailand
Teijin to Produce Prosthetic Joints in Thailand
Teijin Aims to Transform Corporate Culture Through Division-Spanning Businesses
Teijin Aims to Transform Corporate Culture Through…
Teijin Seeks 10% Annual Growth for Functional Food Ingredients
Teijin Seeks 10% Annual Growth for Functional Food…
Chemical and Material Companies Look to Take Pharmaceutical Operations to the Next Stage
Chemical and Material Companies Look to Take Pharmaceutical…
Teijin President Jun Suzuki Discusses Company Efforts to Still Achieve Targets in Face of COVID-19 Impact
Teijin President Jun Suzuki Discusses Company Efforts to…
Large Japanese Chemical and Material Firms to Generate Earnings from Health Care
Large Japanese Chemical and Material Firms to Generate…